SCHEMBL21870764

SCHEMBL21870764

CC[C@@H](c1c[nH]c2ccccc12)[C@H](N)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 3/20 0.59
FFAR1 O14842 2/20 0.52
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
MAPT P10636 3/20 0.51
KDM4E B2RXH2 3/20 0.51
LMNA P02545 1/20 0.51
MPO P05164 1/20 0.51
TSHR P16473 1/20 0.51
BLM P54132 1/20 0.51
PMP22 Q01453 1/20 0.51
HIF1A Q16665 1/20 0.51
PKM P14618 1/20 0.51
HTR2A P28223 2/20 0.49
HTR2C P28335 1/20 0.49
HTR2B P41595 1/20 0.49
MGAM O43451 2/20 0.48
GAA P10253 2/20 0.48
SI P14410 2/20 0.48
MGAM2 Q2M2H8 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL840122 1.00 GPR84 (0.59) GPR84FFAR1MEN1KMT2AMAPT
SCHEMBL31641721 0.89 GPR84 (0.61) GPR84FFAR1MEN1KMT2AMAPT
SCHEMBL20551986 0.89 GPR84 (0.61) GPR84FFAR1MEN1KMT2AMAPT
SCHEMBL31000506 0.89 GPR84 (0.61) GPR84FFAR1MEN1KMT2AMAPT
SCHEMBL31641611 0.89 GPR84 (0.61) GPR84FFAR1MEN1KMT2AMAPT
SCHEMBL31646294 0.89 GPR84 (0.61) GPR84FFAR1MEN1KMT2AMAPT
SCHEMBL21870762 0.89 GPR84 (0.61) GPR84FFAR1MEN1KMT2AMAPT
SCHEMBL31642552 0.89 GPR84 (0.61) GPR84FFAR1MEN1KMT2AMAPT
SCHEMBL31641958 0.88 HTR2A (0.51) GPR84FFAR1MEN1KMT2AMAPT
SCHEMBL31642540 0.88 HTR2A (0.51) GPR84FFAR1MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12024731-B2 Methods and enzyme catalysts for the synthesis of non-canonical amino acids CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2024-07-02 US disclosed
US-12024731-B2 Methods and enzyme catalysts for the synthesis of non-canonical amino acids CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2024-07-02 US disclosed
US-20200340024-A1 METHODS AND ENZYME CATALYSTS FOR THE SYNTHESIS OF NON-CANONICAL AMINO ACIDS CALIFORNIA INSTITUTE OF TECHNOLOGY 2020-10-29 US disclosed
US-10612056-B2 Beta-substituted non-canonical amino acids CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2020-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12024731-B2 Methods and enzyme catalysts for the synthesis of non-canonical amino acids AANAT, AADAT, TPH1 GPR84 3894/4885FFAR1 3292/4885MEN1 3675/4885
US-20200340024-A1 METHODS AND ENZYME CATALYSTS FOR THE SYNTHESIS OF NON-CANONICAL AMINO ACIDS AANAT, AADAT, TPH1 GPR84 3894/4885FFAR1 3292/4885MEN1 3675/4885
US-10612056-B2 Beta-substituted non-canonical amino acids AANAT, TPH1, AADAT GPR84 3415/4885FFAR1 2270/4885MEN1 3499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.